HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of human T-cell leukemia virus type I proviral sequences from fixed tissues of seropositive patients.

Abstract
Fixed lymphoma tissues from 11 patients seropositive for human T-cell leukemia virus type I (HTLV-I) antibodies were analyzed for proviral sequences by the polymerase chain reaction. Typical adult T-cell leukemia/lymphomas (ATLLs) from nine patients were positive for HTLV-I sequences. In contrast, one of two lymphomas with immunophenotypes atypical for ATLL was negative for HTLV-I. This HTLV-I DNA-negative lymphoma, although present in an HTLV-I-seropositive patient, was therefore reclassified. The HTLV-I tax gene was always detected in the ATLL tissues, whereas segments of the pol gene were not detected in half the cases. These studies demonstrate that fixed non-ATLL specimens can be distinguished from ATLL specimens.
AuthorsD Shibata, M Tokunaga, N Sasaki, K Nanba
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 95 Issue 4 Pg. 536-9 (Apr 1991) ISSN: 0002-9173 [Print] England
PMID2014780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA, Viral
Topics
  • Adult
  • Aged
  • DNA, Viral (genetics)
  • Diagnosis, Differential
  • Female
  • Genes, pX (genetics)
  • Genes, pol (genetics)
  • HIV Seropositivity (genetics, microbiology)
  • Human T-lymphotropic virus 1 (genetics, isolation & purification)
  • Humans
  • Immunophenotyping
  • Leukemia-Lymphoma, Adult T-Cell (diagnosis, genetics, microbiology)
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Proviruses (genetics, isolation & purification)
  • Serologic Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: